ReviewNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2025
Anti-Kelch-like protein 11 antibody encephalitis presenting with progressive cognitive deficits in an older woman: a case report and literature review.
Review in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Nationwide screening identifies an expanded clinical spectrum of anti-KLHL11 antibody-associated neurologic disease in Japan.Journal of neurology · 2026Observational
- Anti-KLHL11 antibody encephalitis without detectable malignancy: a case report and literature review.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAnti-Kelch-like protein 11 (KLHL11) antibody encephalitis is very rare,with a much lower incidence in female patients,and has not been reported to cause progressive cognitive impairment.We report a case of a 65-year-old woman who presented with progressive cognitive impairment. CASE PRESENTATION: A 65-year-old woman presented with progressive cognitive impairment and pathological hypersomnia (>15 hours/day) for six months.On admission, neurological examination revealed severe cognitive impairment (MMSE 8/30; MoCA 9/30).The contrast-enhanced brain MRI scan showed a subcortical patchy intensifying lesion in her left frontal lobe,and the cell-based assay (CBA) showed positive anti-KLHL11 antibodies in both her serum (1:320)and CSF(1:32). This patient was diagnosed with anti-Kelch-like protein 11 (KLHL11) antibody encephalitis and received intravenous methylprednisolone at a daily dose of 1 g for 5 days with slight symptomatic relief.The patient was discharged without receiving further treatment. At the 13-month follow-up after discharge, she was still alive but slept for more than 20 hours a day and did not recognise anyone.We also conducted a literature review of reported female patients with positive anti-KLHL11 antibodies to summarize the characteristics of the disease and improve clinicians' understanding of this illness in female patients.
conclusionThis case broadens the clinical and radiological spectrum of anti-KLHL11 encephalitis in women. The literature review revealed that female patients may present with more diverse symptoms. Clinicians should remain alert to this diagnosis in female patients, particularly when opsoclonus-myoclonus is presented, and should concurrently assess for underlying ovarian teratomas or malignancy.
Indexed as
Identifiers
40936049What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.